• SENSEX 77,540.83
    3.11 (+0.00%)
  • BANKNIFTY 57,761.95
    266.05 (+0.46%)
  • HDFC Bank
    732.85 1,020.35(%)
  • Welspun Corp
    2,348.30 2,348.30(%)
  • 360 ONE
    1,190.00 906.20(%)
  • Shadowfax Technologies
    259.85 268.55(%)
  • Hyundai Motor I
    2,210.85 1,658.45(%)
  • Netweb Technol.
    5,675.00 5,675.00(%)
  • Dhoot Transmission
    1,523.85 1,523.85(%)
  • KDDL Ltd
    4,065.00 4,150.00(%)
  • N S D L
    839.00 1,382.00(%)
  • Deepak Nitrite
    1,726.00 1,280.40(%)
  • Pine Labs
    156.25 134.75(%)
  • Balrampur Chini
    714.30 393.40(%)
  • Radico Khaitan
    4,613.30 2,504.60(%)
  • Interglobe Aviat
    5,053.75 3,894.80(%)
  • Hindustan Copper
    581.00 759.20(%)
  • Cupid
    287.95 298.95(%)
  • HDFC AMC
    2,596.70 2,206.05(%)
  • Himadri Special
    650.25 420.00(%)
  • Meesho
    204.40 125.70(%)
  • Shiprocket
    136.72 129.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Terce Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3500.0
  • ISIN : INE499G01013
37.62 1 (3.49%)
  • As on 21 Aug 2026 (EOD)

  • Today’s Low

    35.43

  • Today’s High

    37.65

  • Open

    36.50

  • Perv Close

    36.35

  • 52W Low

    29.00

  • 52W High

    59.78

Key Indicators

  • P/E(TTM)

    13.15

  • Mar.Cap (₹Cr.)

    29.31

  • Div & Yield %

    0.00

  • Book Value(₹)

    12.49

  • Debt-Equity Ratio

    3.49

  • AGM Date

    21-Aug-2026

  • EPS

    2.86

  • P/E Ratio

    13.15

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    29.31

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.79

  • BV (₹)

    12.50

  • Sales( ₹ in Cr.)

    47.47

  • NP (in Cr.)

    2.46

  • NP Var(%)

    347.0

  • Div%

    0.0

  • CPS (₹)

    3.70

  • EPS (₹)

    3.20

  • Traded Value (₹ in Lakhs)

    29.31

  • 52 Week High

    59.78

  • 52 Week Low

    29.00

  • Price BSE

    38.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    29.31

  • P/C Ratio

    10.30

  • P/E Ratio

    12.10

  • Price Vs.BV

    3.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 47.47 50.20 47.97 46.78 40.13 25.18
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 47.47 50.20 47.97 46.78 40.13 25.18
Other Income 0.34 0.31 0.32 0.35 0.31 0.80
Stock Adjustments 0.42 0.38 -1.04 -1.65 2.63 0.26
Total Income 48.23 50.89 47.25 45.48 43.07 26.24
EXPENDITURE :            
Raw Materials 17.56 19.35 16.65 17.70 17.88 10.25
Power and Fuel Cost 0.13 0.15 0.17 0.11 0.16 0.10
Employee Cost 14.89 15.37 15.11 14.38 15.49 12.63
Other Manufacturing Expenses 0.69 0.55 0.22 0.44 1.58 0.93
Selling and Administration Expenses 10.79 11.21 13.44 14.57 5.97 3.93
Miscellaneous Expenses 0.55 0.06 0.07 0.10 0.56 0.37
Employee Benefit Expenses 14.89 15.37 15.11 14.38 15.49 12.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 44.60 46.69 45.67 47.29 41.65 28.20
Operating Profit 3.64 4.20 1.59 -1.81 1.42 -1.97
Interest 0.18 0.42 0.68 0.72 0.40 0.39
Gross Profit 3.46 3.78 0.91 -2.53 1.02 -2.36
Depreciation 0.42 0.38 0.37 0.36 0.28 0.18
Profit Before Tax 3.04 3.40 0.54 -2.89 0.74 -2.54
Current Tax 1.09 0.16 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.26 4.21 0.30 -1.22 -0.13 -0.01
Reported Net Profit 2.20 -0.98 0.24 -1.67 0.87 -2.52
Extraordinary Items -0.25 0.01 0.00 0.00 0.00 -0.18
Adjusted Net Profit 2.45 -0.99 0.24 -1.67 0.87 -2.34
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.93
P & L Balance brought forward -3.21 -2.23 -2.48 -0.80 -1.68 1.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -1.01 -3.21 -2.23 -2.48 -0.80 -1.68
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.83 -1.32 0.33 -2.25 1.18 -3.40
Earnings Per Share(Adj)-Unit Curr 2.83 -1.32 0.33 -2.25 1.18 -3.40
Book Value 12.49 8.26 9.58 9.25 11.50 10.33
Book Value(Adj)-Unit Curr 12.49 8.26 9.58 9.25 11.50 10.33

Shareholding Pattern

  • Promoter Group

    40.03%

  • Public Share Holding

    59.97%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,075,900 13.81 1,075,900 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 7,500 0.10 7,500 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,035,284 26.12 2,035,284 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,118,684 40.03 3,118,684 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 135,426 1.74 133,826 27
Clearing Members 1,834 0.02 1,834 2
Directors of their Relatives 300 0.00 300 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 141,546 1.82 141,546 29
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 157,521 2.02 157,521 99
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,073,283 13.78 1,072,983 28
Individuals holding nominal share capital up to Rs. 1 lakh 3,162,606 40.59 2,002,856 13,562
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,672,616 59.97 3,510,966 13,749
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,791,300 100.00 6,629,650 13,755

Company Background

Gujarat Terce Laboratories LtdPharmaceuticals - Indian - Formulations

  • Gujarat Terce Laboratories Ltd
  • BSE Code : 3500.0
  • ISIN : INE499G01013

  • Incorporation Year

    1985

  • Registered Office

    122/2 Ravi Estate
    Bileshwarpura Chhatral, Gandhinagar,
    Gujarat-382729

  • Telephone

    91-079-6663 3706

  • FAX

  • Chairman

    Natwarbhai P Prajapati

  • Managing Director

    Aalap Prajapati

  • Company Secretary

    Ripalben Sachinkumar Sukhadiya

  • Auditor

    Shah Doshi Patel & Associates LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Gujarat Terce Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Terce Labs. 37.62 47.81 47.47 14.04 27.03
Abbott India 26,245.55 7,217.19 6,929.05 34.54 43.78
Astrazeneca Phar 7,410.50 2,304.07 2,275.58 109.22 27.86
Glaxosmi. Pharma 2,899.60 3,932.76 3,790.20 46.32 58.17
Cipla 1,426.20 20,102.60 18,979.95 37.48 13.88
Novartis India 1,423.40 398.23 356.27 35.94 16.64
Bliss GVS Pharma 582.25 773.53 729.81 54.06 12.51
Amrutanjan Healt 536.60 469.50 451.82 28.74 21.89
Fermenta Biotec. 478.20 474.15 450.25 22.32 18.77
Guj. Themis Bio. 380.90 152.47 150.80 85.21 27.21
Ambalal Sarabhai 45.28 19.52 3.94 83.85 6.77